June 23, 2020 / 11:27 PM / 12 days ago

BRIEF-GW Pharmaceuticals Announces Epidyolex® Has Been Reclassified By The Uk Home Office As A Schedule 5 Drug

June 23 (Reuters) - GW Pharmaceuticals PLC:

* GW PHARMACEUTICALS ANNOUNCES THAT EPIDYOLEX® (CANNABIDIOL) HAS BEEN RECLASSIFIED BY THE UK HOME OFFICE AS A SCHEDULE 5 DRUG

* CHANGE WILL TAKE EFFECT IMMEDIATELY IN ALL FOUR OF CONSTITUENT NATIONS OF UK - WITH NORTHERN IRELAND Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below